Taking advantage of the Medtech market potential in India: success will hinge on operating model innovation
Medical technology (Medtech) companies are accelerating their investments in emerging markets, and India is a prime target because of its large population, growing middle class, and improving healthcare infrastructure. To date, most Medtech multinationals have pursued a conservative business strategy and operating model in India, focused on delivering their existing offerings to the premium segments of the market. But the playing field is becoming far more competitive, and companies in search of growth need to move beyond the traditional model.
To gain perspective on this topic, PwC recently surveyed executives from leading global and domestic Medtech companies with India operations representing $1.3 billion in revenues in India, or roughly 40% of the $3 billion Indian market. Their responses, combined with in-depth interviews and PwC’s research and experience in the industry, provide insight on how to succeed in India.
To read the full report visit www.pwc.com/medtechindiastudy